SCHEMBL7358193

SCHEMBL7358193

[c]1ncc(-c2ccccn2)c(-c2cccnc2)n1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 5/20 0.57
NPC1 O15118 2/20 0.45
TP53 P04637 2/20 0.45
RAB9A P51151 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
PKM P14618 1/20 0.45
TSHR P16473 1/20 0.45
PIM1 P11309 2/20 0.43
PIM2 Q9P1W9 1/20 0.43
GRM5 P41594 2/20 0.41
CYP1A2 P05177 2/20 0.39
ALDH1A1 P00352 1/20 0.39
CYP3A4 P08684 1/20 0.39
DCTPP1 Q9H773 1/20 0.39
CYP11B1 P15538 1/20 0.37
CYP11B2 P19099 1/20 0.37
PTGS2 P35354 1/20 0.37
IDO1 P14902 1/20 0.37
LRRK2 Q5S007 1/20 0.37
CYP19A1 P11511 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20985616 0.83 KDM4E (0.45) CYP2A6NPC1TP53RAB9ASMN1; SMN2
SCHEMBL16060090 0.80 KDM4E (0.42) CYP2A6NPC1TP53RAB9ASMN1; SMN2
SCHEMBL7014981 0.79 CYP2A6 (0.60) CYP2A6NPC1TP53RAB9ASMN1; SMN2
SCHEMBL18952605 0.75 TGFBR1 (0.40) NPC1PIM1GRM5CYP1A2DCTPP1
[2,3'']Bipyridinyl SCHEMBL29360744 0.74 CYP2A6 (1.00) CYP2A6NPC1TP53RAB9ASMN1; SMN2
[2,3'']Bipyridinyl SCHEMBL29389597 0.74 CYP2A6 (1.00) CYP2A6NPC1TP53RAB9ASMN1; SMN2
[2,3'']Bipyridinyl SCHEMBL998601 0.74 CYP2A6 (1.00) CYP2A6NPC1TP53RAB9ASMN1; SMN2
[2,3'']Bipyridinyl SCHEMBL29486847 0.74 CYP2A6 (1.00) CYP2A6NPC1TP53RAB9ASMN1; SMN2
SCHEMBL27668844 0.74 CYP2A6 (0.60) CYP2A6NPC1TP53RAB9ASMN1; SMN2
[2,3'']Bipyridinyl SCHEMBL1418333 0.72 CYP2A6 (0.96) CYP2A6NPC1TP53RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1454211-A Nitrogen containing heterobicycles as factor xa inhibitors BRISTOL MYERS SQUIBB PHARMA CO (US) 2003-11-05 CN disclosed
EP-1175419-A2 ARYL SULFONYLS AS FACTOR XA INHIBITORS Du Pont Pharmaceuticals Company (US) 2002-01-30 EP disclosed
WO-1999032454-A9 NITROGEN CONTAINING HETEROAROMATICS WITH ORTHO-SUBSTITUTED P1'S AS FACTOR XA INHIBITORS DU PONT PHARM CO (US) 2001-05-31 WO disclosed
WO-2000059902-A2 ARYL SULFONYLS AS FACTOR XA INHIBITORS DU PONT PHARMACEUTICALS COMPANY (US) 2000-10-12 WO disclosed
EP-1042299-A1 NITROGEN CONTAINING HETEROAROMATICS WITH ORTHO-SUBSTITUTED P1'S AS FACTOR XA INHIBITORS Du Pont Pharmaceuticals Company (US) 2000-10-11 EP disclosed
EP-0946528-A2 OXYGEN OR SULFUR CONTAINING 5-MEMBERED HETEROAROMATICS AS FACTOR Xa INHIBITORS Du Pont Pharmaceuticals Company (US) 1999-10-06 EP disclosed
WO-1999032454-A1 NITROGEN CONTAINING HETEROAROMATICS WITH ORTHO-SUBSTITUTED P1'S AS FACTOR XA INHIBITORS DU PONT PHARMACEUTICALS COMPANY (US) 1999-07-01 WO disclosed
WO-1998028282-A2 OXYGEN OR SULFUR CONTAINING 5-MEMBERED HETEROAROMATICS AS FACTOR Xa INHIBITORS DU PONT PHARMACEUTICALS COMPANY (US) 1998-07-02 WO disclosed